Sunzen Group Berhad (KLSE:SUNZEN)

Malaysia · Delayed Price · Currency is MYR

0.2250

+0.0050 (2.27%)

At close: Aug 28, 2026

-16.67% (1Y)

Market Cap	178.63M -14.2%
Revenue (ttm)	93.51M +16.0%
Net Income	10.29M +298.1%
EPS	0.01 +332.3%
Shares Out	793.92M
PE Ratio	18.60
Forward PE	n/a
Dividend	0.00 (1.74%)
Ex-Dividend Date	Dec 12, 2025

Volume	270,200
Open	0.2200
Previous Close	0.2200
Day's Range	0.2150 - 0.2250
52-Week Range	0.2150 - 0.2950
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2026

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition... [Read more]

Industry Pharmaceutical Preparations

Founded 1998

Employees 168

Stock Exchange Bursa Malaysia

Ticker Symbol SUNZEN

Full Company Profile

Financial Performance

In fiscal year 2026, Sunzen Group Berhad's revenue was 93.51 million, an increase of 16.05% compared to the previous year's 80.58 million. Earnings were 10.29 million, an increase of 298.09%.

Financial Statements